“FW Capital had the funds which we could utilise and they were local to us. The relationship we had was good from the start, open and transparent. They understood what we wanted to achieve and were very efficient. They acted swiftly and we got a credit-approved offer in a matter of weeks.”
Established in 2015 by experienced life science entrepreneurs Ian Shott and Paul Ryan, Arcinova is an independent pharmaceutical contract research and development company. Operating from a facility in Alnwick, it services a range of international life science businesses, helping them to take new medicines through the clinical development process quickly, effectively and with minimum risk.
In 2016 FW Capital provided Arcinova with a £750,000 loan from the North East Growth Plus Fund to support its plans for significant growth - helping the business to increase capability, broaden its range of services and take on more staff. The funding also enabled Arcinova to invest in its Active Pharmaceutical Ingredient manufacturing facility and meet the needs of its growing customer base.